Geographic variations in activity of broad-spectrum β-lactams against Pseudomonas aeruginosa: Summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000)

Diagnostic Microbiology and Infectious Disease

Volumn 43, Issue 3, 2002, Pages 239-243

  Jones, Ronald N ^a,b   Kirby, Jeffrey T ^a   Beach, Mondell L ^a   Biedenbach, Douglas J ^a   Pfaller, Michael A ^c  

^a JMI LABORATORIES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TICARCILLIN; TIMENTIN; TOBRAMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLINICAL LABORATORY; CONTROLLED STUDY; DILUTION; DRUG EFFECT; DRUG POTENCY; GEOGRAPHICAL VARIATION (SPECIES); HEALTH CENTER; HEALTH PROGRAM; MICROBIAL SENSITIVITY TEST; NONHUMAN; NORTH AMERICA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SOUTH AND CENTRAL AMERICA; STANDARD;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BETA-LACTAMS; CEFTAZIDIME; CEPHALOSPORINS; FLUOROQUINOLONES; HUMANS; POPULATION SURVEILLANCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; WORLD HEALTH;

EID: 0036065086     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00390-5     Document Type: Article

References (25)

1. Accuracy of cefepime antimicrobial susceptibility testing results for Pseudomonas aeruginosa tested on the MicroScan WalkAway System
2. Mechanisms of β-lactam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey
3. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa
4. Emergence of antibiotic-resistant Pseudomonas aeruginosa: Comparison of risks associated with different antipseudomonal agents
5. Clinical evaluation of the Vitek automated system with cards GNS 122 and 127 and VTK-R07.01 software for antimicrobial susceptibility testing of Pseudomonas aeruginosa
6. A seven year survey of antibiotic susceptibility and its relationship with usage
7. Survey of bloodstream infections due to gram-negative bacilli: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997
8. Ventilator-associated pneumonia - Understanding epidemiology and pathogenesis to guide prevention and empiric therapy
9. Characterization of Pseudomonas aeruginosa isolates: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999
10. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries
11. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria
12. Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults: Case report and review of the literature
13. Incorrect and inconsistent reporting of cefepime MIC values against Pseudomonas aeruginosa on the MicroScan and Vitek systems
14. Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime
15. Antimicrobial activity and spectrum investigation of eight broad-spectrum β-lactam drugs: A 1997 surveillance trial in 102 medical centers in the United States
16. Development of bacterial resistance to the third generation cephalosporins and their clinical use
17. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997)
18. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella
19. Comparison of the activity of two broad-spectrum cephalosporins tested against 2,299 strains of Pseudomonas aeruginosa isolated at 38 North American medical centers participating in the SENTRY antimicrobial surveillance program, 1997-1998
20. Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora
21. Nosocomial infections in medical intensive care units in the United States
22. Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study